Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YSPSL for Prevention of Delayed Graft Function in Kidney Transplantation
NCT00298168Phase 2Completed
- Start
- May 2006
- Primary completion
- Sep 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rPSGL-Ig in delayed graft function (DGF) (3 arms). Primary endpoint: Delayed Graft Function at 6 months. Started May 2006; status: completed.
02
Drugs
rPSGL-Ig
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT00298168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298168.